Apollomics (APLM) Enterprise Value (2020 - 2025)
Apollomics (APLM) posted quarterly Enterprise Value of -$3.3 million for Q4 2025, up 66.46% year-on-year from -$2.0 million in Q4 2024, and down 56.45% on a QoQ basis from -$2.1 million in Q2 2025.
Apollomics (APLM) Enterprise Value (2020 - 2025) Analysis & Trends
Apollomics (APLM) has reported Enterprise Value for 6 consecutive years, with -$3.3 million the latest figure, recorded in Q4 2025.
- Quarterly Enterprise Value rose 66.46% year-over-year to -$3.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.3 million (up 66.46% YoY) and the FY2025 annual result came in at -$3.3 million, up 66.46% from the prior year.
- Enterprise Value retreated to -$3.3 million in Q4 2025 per APLM's latest filing, from -$2.1 million in the prior quarter.
- Over the last five years, Enterprise Value for APLM reached as high as -$2.1 million in Q2 2025 and fell as low as -$51.7 million in Q4 2022.
- A 5-year average of -$28.6 million and a median of -$30.2 million in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 71.16% — and 2025, when it surged 91.92%.
- Year by year, Enterprise Value stood at -$30.2 million in 2021, then tumbled by 71.16% to -$51.7 million in 2022, then gained by 26.91% to -$37.8 million in 2023, then jumped by 74.18% to -$9.8 million in 2024, then surged by 66.46% to -$3.3 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$3.3 million, -$2.1 million, and -$9.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | -3.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.28 Mn |
| Jun 30, 2025 | -2.09 Mn |
| Dec 31, 2024 | -9.77 Mn |
| Jun 30, 2024 | -25.93 Mn |
| Dec 31, 2023 | -37.82 Mn |
| Jun 30, 2023 | -45.70 Mn |
| Dec 31, 2022 | -51.74 Mn |
| Jun 30, 2022 | -50.70 Mn |
| Dec 31, 2021 | -30.23 Mn |
| Dec 31, 2020 | -130.65 Mn |